Inactive Instrument
Mymetics Corporation Share Price Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 439K 384K 355K 331K 623K 41.49M 634K 4.25M 1.65M 20.47M 1.65M 1.61M 71.32M | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 72.12M 63.13M 58.28M 54.36M 102M 6.82B 104M 699M 271M 3.37B 271M 265M 11.72B | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 18/11/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| +3.31% | -0.20% | +72.71% | +128.31% | 55.78B | |
| -1.32% | +16.55% | +89.14% | +101.41% | 55.66B | |
| -0.73% | +3.16% | -12.20% | -13.39% | 23.84B | |
| +3.16% | +5.16% | +6.74% | +409.10% | 22.7B | |
| +4.45% | +5.06% | +36.50% | -30.43% | 16.12B | |
| +0.53% | +6.42% | +23.96% | +185.90% | 13.64B | |
| +5.51% | +22.37% | +171.85% | +333.54% | 14.8B | |
| +0.92% | +3.76% | +76.03% | +130.63% | 12.16B | |
| -2.11% | +6.95% | +158.99% | +162.32% | 11.85B | |
| Average | +0.38% | +6.15% | +69.30% | +156.38% | 25.17B | |
| Weighted average by Cap. | +1.41% | +5.02% | +66.85% | +142.41% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 430K 376K 347K 324K 611K 40.66M 622K 4.17M 1.62M 20.06M 1.62M 1.58M 69.89M | 1.03M 900K 831K 775K 1.46M 97.2M 1.49M 9.96M 3.87M 47.96M 3.86M 3.78M 167M |
| Net income | -4.73M -4.14M -3.82M -3.57M -6.72M -447M -6.84M -45.84M -17.8M -221M -17.77M -17.37M -769M | -4.8M -4.21M -3.88M -3.62M -6.82M -454M -6.95M -46.57M -18.08M -224M -18.05M -17.65M -781M |
| Net Debt | 67.1M 58.73M 54.22M 50.57M 95.29M 6.34B 96.99M 650M 252M 3.13B 252M 246M 10.91B | 71.68M 62.75M 57.92M 54.03M 102M 6.78B 104M 695M 270M 3.34B 269M 263M 11.65B |
Employees
-
